中华整形外科杂志
中華整形外科雜誌
중화정형외과잡지
CHINESE JOURNAL OF PLASTIC SURGERY
2010年
1期
34-38
,共5页
刘广鹏%李宇琳%孙剑%崔磊%张文杰%曹谊林
劉廣鵬%李宇琳%孫劍%崔磊%張文傑%曹誼林
류엄붕%리우림%손검%최뢰%장문걸%조의림
组织工程%间充质干细胞%颅骨%脱钙骨
組織工程%間充質榦細胞%顱骨%脫鈣骨
조직공정%간충질간세포%로골%탈개골
Tissue engineering%Mesenchymal stem cells%Skull%Calvarial defect
目的 应用人脐血间充质干细胞(umbilical cord blood derived mesenchymal stem cells,UCB-MSCs)复合脱钙骨材料构建组织工程化骨,修复裸大鼠颅骨标准缺损.方法 体外扩增培养、成骨诱导人UCB-MSCs,采用Alizarin Red染色和钙离子半定量的方法测定细胞成骨分化能力.将第2代细胞接种在脱钙骨支架材料上继续诱导培养,扫描电镜检测细胞在材料上的生长状况.制备裸大鼠双侧颅骨全层标准缺损(直径5 mm),一侧以细胞材料复合物修复作为实验侧(n=8);另一侧以单纯脱钙骨材料修复作为对照侧(n=8).术后6、12周取材,分别通过大体形态观察、显微CT(Micro-CT)、组织学方法检测颅骨缺损的修复效果.结果 UCB-MSCs体外能够诱导分化为成骨细胞,且在脱钙骨支架材料上生长良好.Micro-CT检测显示术后6周实验侧有部分新生骨组织形成,12周时骨缺损修复率达(78.19±6.45)%,脱钙骨材料降解完全;对照侧6周时无明显新骨生成,12周时材料完全降解,骨缺损未修复.组织学检测显示12周时实验侧有较多成熟骨生成,为骨性愈合;对照侧骨缺损为纤维愈合.结论 成骨诱导的人UCB.MSCs复合脱钙骨材料构建的组织工程化骨可修复裸大鼠颅骨全层标准缺损,有望成为新的组织工程骨种子细胞来源.
目的 應用人臍血間充質榦細胞(umbilical cord blood derived mesenchymal stem cells,UCB-MSCs)複閤脫鈣骨材料構建組織工程化骨,脩複裸大鼠顱骨標準缺損.方法 體外擴增培養、成骨誘導人UCB-MSCs,採用Alizarin Red染色和鈣離子半定量的方法測定細胞成骨分化能力.將第2代細胞接種在脫鈣骨支架材料上繼續誘導培養,掃描電鏡檢測細胞在材料上的生長狀況.製備裸大鼠雙側顱骨全層標準缺損(直徑5 mm),一側以細胞材料複閤物脩複作為實驗側(n=8);另一側以單純脫鈣骨材料脩複作為對照側(n=8).術後6、12週取材,分彆通過大體形態觀察、顯微CT(Micro-CT)、組織學方法檢測顱骨缺損的脩複效果.結果 UCB-MSCs體外能夠誘導分化為成骨細胞,且在脫鈣骨支架材料上生長良好.Micro-CT檢測顯示術後6週實驗側有部分新生骨組織形成,12週時骨缺損脩複率達(78.19±6.45)%,脫鈣骨材料降解完全;對照側6週時無明顯新骨生成,12週時材料完全降解,骨缺損未脩複.組織學檢測顯示12週時實驗側有較多成熟骨生成,為骨性愈閤;對照側骨缺損為纖維愈閤.結論 成骨誘導的人UCB.MSCs複閤脫鈣骨材料構建的組織工程化骨可脩複裸大鼠顱骨全層標準缺損,有望成為新的組織工程骨種子細胞來源.
목적 응용인제혈간충질간세포(umbilical cord blood derived mesenchymal stem cells,UCB-MSCs)복합탈개골재료구건조직공정화골,수복라대서로골표준결손.방법 체외확증배양、성골유도인UCB-MSCs,채용Alizarin Red염색화개리자반정량적방법측정세포성골분화능력.장제2대세포접충재탈개골지가재료상계속유도배양,소묘전경검측세포재재료상적생장상황.제비라대서쌍측로골전층표준결손(직경5 mm),일측이세포재료복합물수복작위실험측(n=8);령일측이단순탈개골재료수복작위대조측(n=8).술후6、12주취재,분별통과대체형태관찰、현미CT(Micro-CT)、조직학방법검측로골결손적수복효과.결과 UCB-MSCs체외능구유도분화위성골세포,차재탈개골지가재료상생장량호.Micro-CT검측현시술후6주실험측유부분신생골조직형성,12주시골결손수복솔체(78.19±6.45)%,탈개골재료강해완전;대조측6주시무명현신골생성,12주시재료완전강해,골결손미수복.조직학검측현시12주시실험측유교다성숙골생성,위골성유합;대조측골결손위섬유유합.결론 성골유도적인UCB.MSCs복합탈개골재료구건적조직공정화골가수복라대서로골전층표준결손,유망성위신적조직공정골충자세포래원.
Objective To investigate the feasibility of using human umbilical cord blood derived mesenchymal stem cells (UCB-MSCs) and demineralized bone matrix (DBM) scaffolds to repair critical-sized calvarial defects in athymic rats. Methods Human UCB-MSCs were isolated, expanded and osteogenically induced in vitro. Osteogenic differentiation of UCB-MSCs was evaluated by Alizarin Red staining and measurement of calcium content respectively, and then the cells were seeded onto DBM scaffolds. Bilateral full-thickness defects (5 mm in diameter) of parietal bone were created in an athymic rat model. The defects were either repaired with UCB-MSC/DBM constructs (experimental group) or with DBM scaffolds alone (control group). Animals were harvested at 6 and 12 weeks post-implantation respectively, and defect repair was evaluated with gross observation, micro-CT measurement and histological analysis. Results Micro-CT showed that new bone was formed in the experimental group at 6 weeks post-implantation, while no sign of new bone formation was observed in the control group. At 12 weeks post-transplantation, scaffolds had been degraded almost completely in both sides. It was shown that an average of (78.19±6.45)% of each defect volume had been repaired in experimental side; while in the control side, only limited bone formed at the periphery of the defect. Histological examination revealed that the defect was repaired by trabecular bone tissue in experimental side at 12 weeks, while only fibrous connection was observed in the control group. Conclusions Tissue-engineered bone composed of osteogenically-induced human UCB-MSCs on DBM scaffolds could successfully repair the critical-sized calvarial defects in athymic rat models.